月旦知識庫
 
  1. 熱門:
 
首頁 臺灣期刊   法律   公行政治   醫事相關   財經   社會學   教育   其他 大陸期刊   核心   重要期刊 DOI文章
中醫藥研究論叢 本站僅提供期刊文獻檢索。
  【月旦知識庫】是否收錄該篇全文,敬請【登入】查詢為準。
最新【購點活動】


篇名
中藥配伍的禁忌:十八反與十九畏應用探討
並列篇名
Traditional Chinese Medicine Compatibility Taboo : Application Discussion of the Eighteen Toxic Interactions and the Nineteen Counteracting Interactions
作者 吳柏鋒
中文摘要
關於中藥配伍的禁忌,本文從《神農本草經》的七情配伍為起點,根據歷史文獻的記載與演進,了解十八反與十九畏論述形成的背景與意義。而且本文整理了現代實驗研究成果,從化學成分、藥理與毒理的角度探討這些配伍禁忌的合理性。除此之外,更結合古代文獻記錄與各醫家的用藥經驗加入討論,幫助我們更好理解十八反與十九畏並非絕對禁忌,只是臨床治療還需根據病情病機條件謹慎運用。
英文摘要
About Traditional Chinese Medicine compatibility taboo, this article stated from the seven prescription compatibilitys of “Shennong's compendium of materia medica”, and with the records and development of the historical literatures, we could understand the background and significance of the eighteen toxic interactions and the nineteen counteracting interactions theory formation. With the collections of modern experimental research results, this article discussed the rationality of these compatibility taboo according to the conception of chemical compositions, pharmacology and toxicology. In addition, this discussion combined with the ancient literature records and the prescription experience of physicians could help us realize that the eighteen toxic interactions and the nineteen counteracting interactions theory is not an absolutely taboo. But in clinic al treatment, the prescription compatibility application of physicians must accord to the condition of pathogenesis and be cautious.
起訖頁 51-59
關鍵詞 十八反十九畏配伍禁忌相惡The eighteen toxic interactionsThe nineteen counteracting interactionsCompatibility tabooThe eliminating interactions
刊名 中醫藥研究論叢  
期數 201709 (20:2期)
出版單位 臺北市中醫師公會
該期刊-上一篇 某醫院中藥藥物不良反應研究及探討
該期刊-下一篇 Clozapine 引起過度流涎中西醫病機與治療的文獻回顧
 

新書閱讀



最新影音


優惠活動




讀者服務專線:+886-2-23756688 傳真:+886-2-23318496
地址:臺北市館前路28 號 7 樓 客服信箱
Copyright © 元照出版 All rights reserved. 版權所有,禁止轉貼節錄